Piramal Pharma Limited (BOM:543635)

Market Cap	262.48B
Revenue (ttm)	91.34B
Net Income (ttm)	980.70M
Shares Out	n/a
EPS (ttm)	0.73
PE Ratio	267.64
Forward PE	94.67
Dividend	0.14 (0.07%)
Ex-Dividend Date	Jul 16, 2025

Volume	49,954
Average Volume	168,236
Open	194.95
Previous Close	195.55
Day's Range	193.25 - 197.75
52-Week Range	180.35 - 307.85
Beta	n/a
RSI	51.10
Earnings Date	Oct 28, 2025

About Piramal Pharma

Piramal Pharma Limited operates as a pharmaceutical company in the United States, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities and distribution network. It also operates contract development and manufacturing organization that provides services across the drug life cycle, including discovery, development, and commercial manufacturing of drug substances and products; offers inhalation anesthetics, intrathecal therapy, inje...

• Industry: Pharmaceutical Preparations
• Founded: 2020
• Employees: 5,476
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 543635

Financial Performance

In 2024, Piramal Pharma's revenue was 91.51 billion, an increase of 11.99% compared to the previous year's 81.71 billion. Earnings were 911.30 million, an increase of 411.39%.